Company: PSTV
Filing Date: 2025-04-01
Form Type: PRER14A
Source: 0001140361-25-011649
Chunk: 5

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-01
Form: PRER14A
Chunk 5
---
 Common Stock in the case of the Series B Warrants (in each case subject to the potential for further adjustments), and certain provisions of the Series A Warrants and Series B Warrants, issued in connection with an offering and sale of securities in a private placement of the Company that was consummated on March 4, 2025 (the “Issuance Proposal”); |

| • | Proposal 3: To amend the Certificate of Incorporation to increase the authorized shares of Common Stock from 100,000,000 shares to 2,000,000,000 shares (the “Authorized Common Stock Increase Proposal”); |

| • | Proposal 4: To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the extension of the term of the Company’s May 2024 Warrants (as defined elsewhere in this Proxy Statement) (the “Warrant Amendment Proposal”); |

| • | Proposal 5: To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Issuance Proposal, the Authorized Common Stock Increase Proposal and the Warrant Amendment Proposal, if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, the Issuance Proposal, the Authorized Common Stock Increase Proposal or the Warrant Amendment Proposal (the “Adjournment Proposal”); and |

| • | To transact any other business that may properly come before the Special Meeting or any adjournment(s) or postponements of the Special Meeting. |

2

TABLE OF CONTENTS

What are the Board’s voting recommendations? The Board recommends that you vote as follows:

| • | Proposal 1 (Reverse Stock Split Proposal): “FOR” the Reverse Stock Split Proposal; |

| • | Proposal 2 (Issuance Proposal): “FOR” the Issuance Proposal; |

| • | Proposal 3 (Authorized Common Stock Increase Proposal): “FOR” the Authorized Common Stock Increase Proposal; |

| • | Proposal 4 (Warrant Amendment Proposal): “FOR” the Warrant Amendment Proposal; and |

| • | Proposal 5 (Adjournment Proposal): “FOR” the Adjournment Proposal. |

Who is entitled to vote at the Special Meeting? Holders of record of our Common Stock, as of the close of business on March 4, 2025, the record date for the Special Meeting (the “Record Date”), are entitled